Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas

Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas

The effects of cardiac disease on the intestine have been reported in humans but not in dogs. We investigated the effects of myxomatous mitral valve disease (MMVD), which is capable of causing congestion and tissue hypoperfusion, on the intestine in Chihuahuas, a breed frequently encountered in clin...

Full description

Bibliographic Details
Main Authors:	R. Araki, K. Iwanaga, Kazunori Ueda, M. Isaka
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Veterinary Science
Subjects:	Chihuahuas D-lactate intestinal complication intestinal fatty acid-binding protein intestinal mucosal injury markers myxomatous mitral valve disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fvets.2021.777579/full

Similar Items

Comparison of Intestinal Microbiota Between Healthy and MMVD Chihuahuas Using 16S rRNA Gene Amplicon Sequencing
by: Ryuji Araki, et al.
Published: (2022-03-01)

Mitral annulus dynamics in myxomatous mitral valve disease
by: Maria-Magdalena Gurzun, et al.
Published: (2021-03-01)

Myxomatous Mitral Valve Disease with Mitral Valve Prolapse and Mitral Annular Disjunction: Clinical and Functional Significance of the Coincidence
by: Nina C. Wunderlich, et al.
Published: (2021-01-01)

Evaluation of the corrected QT interval with Bazett’s Method in Cavalier King Charles Spaniel dogs with myxomatous mitral valve disease
by: Hande Sağoğlu, et al.
Published: (2023-03-01)

Mediators of intracellular interactions and endothelial function in myxomatous mitral valve prolapse
by: A. V. Yagoda, et al.
Published: (2013-02-01)

Pro-Inflammatory and Immunological Profile of Dogs with Myxomatous Mitral Valve Disease
by: Diego Piantedosi, et al.
Published: (2022-06-01)

Diagnostic value of echocardiographic indices of left atrial and ventricular morphology in dogs with myxomatous mitral valve disease (MMVD)
by: R. M. Trofimiak, et al.
Published: (2021-03-01)

Mitral valve prolapse
by: Nekkanti Venkat Rayudu
Published: (2018-01-01)

Differentially expressed platelet activation-related genes in dogs with stage B2 myxomatous mitral valve disease
by: Qingqing Zhou, et al.
Published: (2023-12-01)

Retrospective evaluation of notched and fragmented QRS complex in dogs with naturally occurring myxomatous mitral valve disease
by: Radu Andrei Baisan, et al.
Published: (2021-12-01)

Prognostic value of serum cystatin C concentration in dogs with myxomatous mitral valve disease
by: Naoki Iwasa, et al.
Published: (2023-03-01)

Serum Proteomic Profiles Reflect the Stages of Myxomatous Mitral Valve Disease in Dogs
by: Dina Rešetar Maslov, et al.
Published: (2023-04-01)

Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker
by: Alice Savarese, et al.
Published: (2018-08-01)

The Thoracic Inlet Length as a Reference Point to Radiographically Assess Cardiac Enlargement in Dogs with Myxomatous Mitral Valve Disease
by: David Marbella Fernández, et al.
Published: (2023-08-01)

Development of an artificial intelligence-based method for the diagnosis of the severity of myxomatous mitral valve disease from canine chest radiographs
by: Carlotta Valente, et al.
Published: (2023-09-01)

Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease
by: Amaia Garcia-Pena, et al.
Published: (2021-02-01)

Proteomic analysis of the serum in dogs with pulmonary hypertension secondary to myxomatous mitral valve disease: the preliminary study
by: Siriwan Sakarin, et al.
Published: (2024-03-01)

Correlation between the Leaflet–Annulus Index and Echocardiographic Indices in Maltese Dogs with Myxomatous Mitral Valve Disease
by: Han-Joon Lee, et al.
Published: (2023-08-01)

Telotristat ethyl reverses myxomatous changes in mice mitral valves
by: Xinmei Wang, et al.
Published: (2022-08-01)

Evaluation of progression of chronic kidney disease in dogs with myxomatous mitral valve disease
by: Hyejin Yun, et al.
Published: (2023-08-01)

Influence of sevoflurane or propofol anaesthesia on oxidative stress parameters in dogs with early-stage myxomatous mitral valve degeneration. A preliminary study
by: Katerina Tomsič, et al.
Published: (2018-03-01)

Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease
by: Hee-Jeong Hong, et al.
Published: (2022-07-01)

Evaluation of antioxidant status and lipid peroxidation in dogs with myxomatous mitral valve degeneration stage B1
by: Katerina Tomsič, et al.
Published: (2023-09-01)

Differences in Levels of Mitochondrial DNA Content at Various Stages of Canine Myxomatous Mitral Valve Disease
by: Suphakan Chirathanaphirom, et al.
Published: (2023-12-01)

Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel
by: G. R. Markby, et al.
Published: (2020-09-01)

Pulmonary Hypertension Secondary to Myxomatous Mitral Valve Disease in Dogs: Current Insights into the Histological Manifestation and Its Determining Factors
by: Arkadiusz Grzeczka, et al.
Published: (2024-03-01)

Genetic Variants at the Nebulette Locus Are Associated with Myxomatous Mitral Valve Disease Severity in Cavalier King Charles Spaniels
by: Sophie E. Mead, et al.
Published: (2022-12-01)

Utility of radiographic measurements to predict echocardiographic left heart enlargement in dogs with preclinical myxomatous mitral valve disease
by: Megan H. Poad, et al.
Published: (2020-09-01)

Machine Learning Techniques for Canine Myxomatous Mitral Valve Disease Classification: Integrating Anamnesis, Quality of Life Survey, and Physical Examination
by: Javier Engel-Manchado, et al.
Published: (2024-03-01)

Prevalence of Reticulocytosis in the Absence of Anemia in Dogs with Cardiogenic Pulmonary Edema Due to Myxomatous Mitral Valve Disease: A Retrospective Study
by: Sol-Ji Choi, et al.
Published: (2022-06-01)

Disease Severity-Associated Gene Expression in Canine Myxomatous Mitral Valve Disease Is Dominated by TGFβ Signaling
by: Greg R. Markby, et al.
Published: (2020-04-01)

Radiographic evaluation of left atrial size in Cavalier King Charles spaniel dogs with mitral valve disease
by: Gonul Remzi, et al.
Published: (2023-10-01)

Management of Chronic Congestive Heart Failure Caused by Myxomatous Mitral Valve Disease in Dogs: A Narrative Review from 1970 to 2020
by: Mara Bagardi, et al.
Published: (2022-01-01)

Can cartilage intermediate layer protein 1 (CILP1) use as a novel biomarker for canine myxomatous mitral valve degeneration levels or not?
by: Hyeon-Jin Kim, et al.
Published: (2023-03-01)

Mitral Annular Disjunction in Mitral Leaflet Prolapse: Prevalence, Clinical Profile and Echocardiographic Features at Tertiary Cardiac Care Centre, Rawalpindi
by: Mutahir Abbas Virk, et al.
Published: (2022-11-01)

Echocardiographic Evaluation of the Mitral Valve in Cavalier King Charles Spaniels
by: Mara Bagardi, et al.
Published: (2020-08-01)

Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease
by: Zohreh Khaki, et al.
Published: (2022-12-01)

Imaging of Mitral Valve Prolapse: What Can We Learn from Imaging about the Mechanism of the Disease?
by: Ronen Durst, et al.
Published: (2015-07-01)

Investigation of red blood cell and platelet indices in adult dogs suffered from myxomatous mitral valve disease with and without pulmonary hypertension
by: Nattawan Tangmahakul, et al.
Published: (2023-09-01)

Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study
by: Beatrice Besche, et al.
Published: (2020-09-01)